vs

Side-by-side financial comparison of Genius Sports Ltd (GENI) and Sensata Technologies Holding plc (ST). Click either name above to swap in a different company.

Sensata Technologies Holding plc is the larger business by last-quarter revenue ($934.8M vs $510.9M, roughly 1.8× Genius Sports Ltd). Sensata Technologies Holding plc runs the higher net margin — 9.3% vs -12.3%, a 21.7% gap on every dollar of revenue. Sensata Technologies Holding plc produced more free cash flow last quarter ($104.6M vs $69.6M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs -5.0%).

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

Sensata Technologies Holding plc is a global industrial technology company that designs, manufactures and sells a broad portfolio of sensing, electrical protection and control solutions. Its products serve automotive, industrial, aerospace, HVAC, telecommunications and heavy vehicle end markets, catering to manufacturing and enterprise clients across the world.

GENI vs ST — Head-to-Head

Bigger by revenue
ST
ST
1.8× larger
ST
$934.8M
$510.9M
GENI
Higher net margin
ST
ST
21.7% more per $
ST
9.3%
-12.3%
GENI
More free cash flow
ST
ST
$35.0M more FCF
ST
$104.6M
$69.6M
GENI
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
-5.0%
ST

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GENI
GENI
ST
ST
Revenue
$510.9M
$934.8M
Net Profit
$-63.0M
$87.1M
Gross Margin
25.2%
30.6%
Operating Margin
-11.5%
15.1%
Net Margin
-12.3%
9.3%
Revenue YoY
2.6%
Net Profit YoY
24.6%
EPS (diluted)
$0.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENI
GENI
ST
ST
Q1 26
$934.8M
Q4 25
$510.9M
$917.9M
Q3 25
$335.4M
$932.0M
Q2 25
$215.2M
$943.4M
Q1 25
$119.7M
$911.3M
Q4 24
$413.0M
$907.7M
Q3 24
$285.8M
$982.8M
Q2 24
$184.1M
$1.0B
Net Profit
GENI
GENI
ST
ST
Q1 26
$87.1M
Q4 25
$-63.0M
$63.2M
Q3 25
$-162.5M
Q2 25
$-47.3M
$60.7M
Q1 25
$-25.5M
$69.9M
Q4 24
$-85.5M
$5.8M
Q3 24
$-47.1M
$-25.0M
Q2 24
$-35.5M
$71.7M
Gross Margin
GENI
GENI
ST
ST
Q1 26
30.6%
Q4 25
25.2%
29.0%
Q3 25
24.2%
27.8%
Q2 25
19.1%
30.3%
Q1 25
10.7%
29.9%
Q4 24
16.7%
27.1%
Q3 24
20.5%
28.6%
Q2 24
18.6%
30.0%
Operating Margin
GENI
GENI
ST
ST
Q1 26
15.1%
Q4 25
-11.5%
10.9%
Q3 25
-15.3%
-13.2%
Q2 25
-21.0%
14.6%
Q1 25
-20.3%
13.4%
Q4 24
-18.0%
8.1%
Q3 24
-13.9%
-20.3%
Q2 24
-16.8%
12.5%
Net Margin
GENI
GENI
ST
ST
Q1 26
9.3%
Q4 25
-12.3%
6.9%
Q3 25
-17.4%
Q2 25
-22.0%
6.4%
Q1 25
-21.3%
7.7%
Q4 24
-20.7%
0.6%
Q3 24
-16.5%
-2.5%
Q2 24
-19.3%
6.9%
EPS (diluted)
GENI
GENI
ST
ST
Q1 26
$0.59
Q4 25
$0.45
Q3 25
$-1.12
Q2 25
$0.41
Q1 25
$0.47
Q4 24
$0.05
Q3 24
$-0.17
Q2 24
$0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENI
GENI
ST
ST
Cash + ST InvestmentsLiquidity on hand
$280.6M
$635.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$724.5M
$2.9B
Total Assets
$1.1B
$6.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENI
GENI
ST
ST
Q1 26
$635.1M
Q4 25
$280.6M
$573.0M
Q3 25
$110.2M
$791.3M
Q2 25
$110.2M
$661.8M
Q1 25
$110.2M
$588.1M
Q4 24
$100.3M
$593.7M
Q3 24
$100.3M
$506.2M
Q2 24
$100.3M
$1.0B
Total Debt
GENI
GENI
ST
ST
Q1 26
Q4 25
$2.8B
Q3 25
Q2 25
Q1 25
Q4 24
$3.2B
Q3 24
Q2 24
Stockholders' Equity
GENI
GENI
ST
ST
Q1 26
$2.9B
Q4 25
$724.5M
$2.8B
Q3 25
$572.4M
$2.7B
Q2 25
$572.4M
$2.9B
Q1 25
$572.4M
$2.8B
Q4 24
$573.0M
$2.9B
Q3 24
$573.0M
$3.0B
Q2 24
$573.0M
$3.0B
Total Assets
GENI
GENI
ST
ST
Q1 26
$6.8B
Q4 25
$1.1B
$6.8B
Q3 25
$792.3M
$7.1B
Q2 25
$792.3M
$7.3B
Q1 25
$792.3M
$7.2B
Q4 24
$775.7M
$7.1B
Q3 24
$775.7M
$7.3B
Q2 24
$775.7M
$8.2B
Debt / Equity
GENI
GENI
ST
ST
Q1 26
Q4 25
1.02×
Q3 25
Q2 25
Q1 25
Q4 24
1.11×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENI
GENI
ST
ST
Operating Cash FlowLast quarter
$81.9M
$122.5M
Free Cash FlowOCF − Capex
$69.6M
$104.6M
FCF MarginFCF / Revenue
13.6%
11.2%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
1.41×
TTM Free Cash FlowTrailing 4 quarters
$33.5M
$508.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENI
GENI
ST
ST
Q1 26
$122.5M
Q4 25
$81.9M
$201.5M
Q3 25
$-4.8M
$159.9M
Q2 25
$-1.2M
$140.9M
Q1 25
$-14.6M
$119.2M
Q4 24
$14.9M
$170.7M
Q3 24
$-9.2M
$130.9M
Q2 24
$143.5M
Free Cash Flow
GENI
GENI
ST
ST
Q1 26
$104.6M
Q4 25
$69.6M
$151.9M
Q3 25
$-14.2M
$136.2M
Q2 25
$-5.8M
$115.5M
Q1 25
$-16.0M
$86.6M
Q4 24
$11.3M
$138.9M
Q3 24
$-11.6M
$91.3M
Q2 24
$98.4M
FCF Margin
GENI
GENI
ST
ST
Q1 26
11.2%
Q4 25
13.6%
16.6%
Q3 25
-4.2%
14.6%
Q2 25
-2.7%
12.2%
Q1 25
-13.4%
9.5%
Q4 24
2.7%
15.3%
Q3 24
-4.1%
9.3%
Q2 24
9.5%
Capex Intensity
GENI
GENI
ST
ST
Q1 26
Q4 25
2.4%
5.4%
Q3 25
2.8%
2.5%
Q2 25
2.1%
2.7%
Q1 25
1.2%
3.6%
Q4 24
0.9%
3.5%
Q3 24
0.9%
4.0%
Q2 24
4.4%
Cash Conversion
GENI
GENI
ST
ST
Q1 26
1.41×
Q4 25
3.19×
Q3 25
Q2 25
2.32×
Q1 25
1.70×
Q4 24
29.50×
Q3 24
Q2 24
2.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons